Top compounds associated with response to RP11-106M3.2


Feature Type Standardized
Nominal ANOVA
mRNA etoposide CTRPv2 pan-cancer AAC -0.2 1e-10
mRNA STF-31 CTRPv2 pan-cancer AAC -0.23 9e-10
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.21 1e-09
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.18 8e-09
mRNA cimetidine CTRPv2 pan-cancer AAC 0.38 1e-08
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.21 1e-08
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 2e-08
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 2e-08
mRNA alisertib CTRPv2 pan-cancer AAC -0.18 3e-08
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.18 5e-08
Download CSV